Psychiatry & Neurology, Clinical Neurophysiology · Chicago, IL
NPI
1124394127
Since 2012
Specialty
Psychiatry & Neurology, Clinical Neurophysiology
Code 2084N0600X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1801 W Taylor St
Chicago, IL, 60612
Phone (312) 996-6496
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
320 services
Medicare patients, 2024
153
Average age 66
Drug cost, 2024
$3.3M
542 prescriptions
Company payments, 2024
$109
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diana Mnatsakanova was code 99214 (office e&m - established), 66 times for 48 patients. In total Diana Mnatsakanova billed 320 services in 24 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 66 | 48 | $73.74 | $4,867 |
| 95886 Electrical Nerve Conductivity | Facility | 44 | 39 | $32.93 | $1,449 |
| 95885 Electrical Nerve Conductivity | Facility | 33 | 21 | $14.58 | $481 |
| 99232 Hospital E&M - Subsequent | Facility | 30 | 14 | $65.19 | $1,956 |
| 95911 Electrical Nerve Conductivity | Facility | 16 | 16 | $99.39 | $1,590 |
| 99213 Office E&M - Established | Facility | 15 | 15 | $43.87 | $658 |
| 99223 Hospital E&M - Initial | Facility | 14 | 14 | $134.75 | $1,886 |
| 95913 Electrical Nerve Conductivity | Facility | 12 | 12 | $135.88 | $1,631 |
| 95912 Electrical Nerve Conductivity | Facility | 12 | 12 | $125.48 | $1,506 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $109.23 | $1,201 |
By year: 2022 $15K for 216 services; 2023 $23K for 318 services; 2024 $22K for 320 services.
Medicare prescription drug claims, 2024
In 2024, the drug Diana Mnatsakanova prescribed most often to Medicare patients was Gabapentin, with 76 prescriptions and refills. In total Diana Mnatsakanova wrote 542 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 76 | 175 | 26 | $2,449 |
| Prednisone Generic | 69 | 159 | 28 | $609 |
| Pyridostigmine Bromide Generic | 65 | 145 | 24 | $7,467 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 45 | 45 | Under 11 | $172K |
| Pregabalin Generic | 41 | 48 | Under 11 | $1,929 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 37 | 37 | Under 11 | $376K |
| Exondys-51 Eteplirsen | 26 | 26 | Under 11 | $1.7M |
| Mycophenolate Mofetil Generic | 19 | 49 | Under 11 | $3,511 |
| Riluzole Generic | 16 | 34 | Under 11 | $3,019 |
| Duloxetine Hcl Generic | 14 | 32 | Under 11 | $283 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 13 | 17 | Under 11 | $44.66 |
Brand drugs: 147 claims; generic drugs: 395 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Diana Mnatsakanova $109 ($109 in general payments such as food, travel and fees) from 1 company. The largest payer was Genzyme Corporation with $109.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 1 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.